194 related articles for article (PubMed ID: 20959328)
1. Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan.
Zelenietz C; Pope J
Ann Rheum Dis; 2010 Nov; 69(11):2055-6. PubMed ID: 20959328
[No Abstract] [Full Text] [Related]
2. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
[TBL] [Abstract][Full Text] [Related]
3. Digital ulcers: overt vascular disease in systemic sclerosis.
Steen V; Denton CP; Pope JE; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
[TBL] [Abstract][Full Text] [Related]
4. Digital ulcers and outcomes assessment in scleroderma.
Matucci-Cerinic M; Seibold JR
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v46-7. PubMed ID: 18784143
[TBL] [Abstract][Full Text] [Related]
5. Bosentan for digital ulcers in patients with systemic sclerosis.
Nagai Y; Hasegawa M; Hattori T; Okada E; Tago O; Ishikawa O
J Dermatol; 2012 Jan; 39(1):48-51. PubMed ID: 21955007
[TBL] [Abstract][Full Text] [Related]
6. Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
Tsifetaki N; Botzoris V; Alamanos Y; Argyriou E; Zioga A; Drosos AA
J Rheumatol; 2009 Jul; 36(7):1550-2. PubMed ID: 19567637
[No Abstract] [Full Text] [Related]
7. Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
Kurgyis Z; Varga R; Sick I; Lang MU; Ruzicka T; Sárdy M
Acta Derm Venereol; 2011 Oct; 91(6):716-7. PubMed ID: 21879251
[No Abstract] [Full Text] [Related]
8. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A
Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
[No Abstract] [Full Text] [Related]
9. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
[TBL] [Abstract][Full Text] [Related]
10. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.
Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V
J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679
[TBL] [Abstract][Full Text] [Related]
11. [Digital ulcers in systemic scleroderma].
Belz D; Hunzelmann N; Moinzadeh P
Hautarzt; 2014 Nov; 65(11):944-8. PubMed ID: 25336296
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with bosentan for refractory digital ulcers in a patient with systemic lupus erythematosus.
Nagai Y; Shimizu A; Ishikawa O
J Dermatol; 2008 Jul; 35(7):447-51. PubMed ID: 18705833
[TBL] [Abstract][Full Text] [Related]
14. Raynaud, digital ulcers and calcinosis in scleroderma.
Nitsche A
Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
[TBL] [Abstract][Full Text] [Related]
15. [Hand involvement in systemic sclerosis].
Mouthon L
Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
[TBL] [Abstract][Full Text] [Related]
16. New hope for systemic sclerosis patients with digital ulcers.
Varga J
Curr Rheumatol Rep; 2005 Apr; 7(2):127-8. PubMed ID: 15760591
[No Abstract] [Full Text] [Related]
17. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis.
Mouthon L; Mestre-Stanislas C; Bérezné A; Rannou F; Guilpain P; Revel M; Pagnoux C; Guillevin L; Fermanian J; Poiraudeau S
Ann Rheum Dis; 2010 Jan; 69(1):214-7. PubMed ID: 19221115
[TBL] [Abstract][Full Text] [Related]
18. Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.
Taniguchi T; Asano Y; Hatano M; Tamaki Z; Tomita M; Kawashima T; Miyazaki M; Sumida H; Akamata K; Takahashi T; Ichimura Y; Toyama T; Sugita M; Noda S; Yao A; Kinugawa K; Sato S
Br J Dermatol; 2012 Feb; 166(2):417-21. PubMed ID: 21848685
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.
Lambova S; Müller-Ladner U
Nat Rev Rheumatol; 2011 Jan; 7(1):5-6. PubMed ID: 21119606
[No Abstract] [Full Text] [Related]
20. Treatment of digital ulcers in systemic sclerosis: Case series study of thirteen patients and discussion on outcome.
Abuowda Y; Almeida RS; Oliveira AA; Pego P; Santos C; Matos-Costa J
Rev Assoc Med Bras (1992); 2017 May; 63(5):422-426. PubMed ID: 28724039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]